MedTrace Logo

Comparison of Two Doses of Intranasal Dexmedetomidine as Premedication in Children

NCT01065701 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2017-10-26

No results posted yet for this study

Summary

Intranasal dexmedetomidine has shown to be an effective sedative when used prior to anaesthetic induction as premedication. 1mcg/kg intranasal dexmedetomidine was used in previous study and it produced satisfactory sedation in more than 50% of the children at the time of anaesthetic induction with no adverse effect. In this study we aim to compare 1mcg/kg with 2mcg/kg intranasal dexmedetomidine in children. We expect more children would attain satisfactory sedation prior to anaesthetic induction when higher dose is used.

Conditions

  • Patient Between 1-8 Years Old Undergoing Elective Surgery at Queen Mary Hospital

Interventions

DRUG

Dexmedetomidine

Intranasal dexmedetomidine is given as premedication prior to induction of anesthesia

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Vivian M Yuen, MBBS · Associate Consultant, Queen Mary Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01065701 on ClinicalTrials.gov